Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Attention deficit hyperactivity disorder symptom self-report in adults in Kenya and its associated risk factors, an analysis from a household survey in a demographic surveillance site.

Jenkins R, Othieno C, Ongeri L, Ogutu B, Sifuna P, Mboroki J, Omollo R.

Glob Ment Health (Camb). 2015 Jul 29;2:e14. doi: 10.1017/gmh.2015.14. eCollection 2015.

2.

Co-occurring Attention Deficit Hyperactivity Disorder symptoms in adults affected by heroin dependence: Patients characteristics and treatment needs.

Lugoboni F, Levin FR, Pieri MC, Manfredini M, Zamboni L, Somaini L, Gerra G, Gruppo InterSert Collaborazione Scientifica Gics.

Psychiatry Res. 2017 Apr;250:210-216. doi: 10.1016/j.psychres.2017.01.052. Epub 2017 Jan 21.

3.

Inattention, Working Memory, and Goal Neglect in a Community Sample.

Elisa RN, Balaguer-Ballester E, Parris BA.

Front Psychol. 2016 Sep 22;7:1428. eCollection 2016.

4.
5.
6.

Quantifying patterns of brain activity: Distinguishing unaffected siblings from participants with ADHD and healthy individuals.

Wolfers T, van Rooij D, Oosterlaan J, Heslenfeld D, Hartman CA, Hoekstra PJ, Beckmann CF, Franke B, Buitelaar JK, Marquand AF.

Neuroimage Clin. 2016 Jul 2;12:227-33. doi: 10.1016/j.nicl.2016.06.020. eCollection 2016.

7.

Early severe institutional deprivation is associated with a persistent variant of adult attention-deficit/hyperactivity disorder: clinical presentation, developmental continuities and life circumstances in the English and Romanian Adoptees study.

Kennedy M, Kreppner J, Knights N, Kumsta R, Maughan B, Golm D, Rutter M, Schlotz W, Sonuga-Barke EJ.

J Child Psychol Psychiatry. 2016 Oct;57(10):1113-25. doi: 10.1111/jcpp.12576. Epub 2016 Jun 6.

8.

Evaluation of the Persistence, Remission, and Emergence of Attention-Deficit/Hyperactivity Disorder in Young Adulthood.

Agnew-Blais JC, Polanczyk GV, Danese A, Wertz J, Moffitt TE, Arseneault L.

JAMA Psychiatry. 2016 Jul 1;73(7):713-20. doi: 10.1001/jamapsychiatry.2016.0465.

9.

Psychometrically Informed Approach to Integration of Multiple Informant Ratings in Adult ADHD in a Community-Recruited Sample.

Martel MM, Nigg JT, Schimmack U.

Assessment. 2017 Apr;24(3):279-289. doi: 10.1177/1073191116646443. Epub 2016 Jul 27.

10.
11.

Rates and Patterns of Comorbidity Among First-Year College Students With ADHD.

Anastopoulos AD, DuPaul GJ, Weyandt LL, Morrissey-Kane E, Sommer JL, Rhoads LH, Murphy KR, Gormley MJ, Gudmundsdottir BG.

J Clin Child Adolesc Psychol. 2016 Feb 6:1-12. doi: 10.1080/15374416.2015.1105137. [Epub ahead of print]

PMID:
26852645
12.

Pharmacokinetics and Exposure-Response Relationships of Dasotraline in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults.

Hopkins SC, Sunkaraneni S, Skende E, Hing J, Passarell JA, Loebel A, Koblan KS.

Clin Drug Investig. 2016 Feb;36(2):137-46. doi: 10.1007/s40261-015-0358-7.

13.

Disorder-specific and shared neurophysiological impairments of attention and inhibition in women with attention-deficit/hyperactivity disorder and women with bipolar disorder.

Michelini G, Kitsune GL, Hosang GM, Asherson P, McLoughlin G, Kuntsi J.

Psychol Med. 2016 Feb;46(3):493-504. doi: 10.1017/S0033291715001877. Epub 2015 Nov 10.

14.

Imaging genetics in adult attention-deficit/hyperactivity disorder (ADHD): a way towards pathophysiological understanding?

Dresler T, Barth B, Ethofer T, Lesch KP, Ehlis AC, Fallgatter AJ.

Borderline Personal Disord Emot Dysregul. 2014 May 12;1:6. doi: 10.1186/2051-6673-1-6. eCollection 2014. Review.

15.

Attention Deficit Hyperactivity Disorder Symptoms, Comorbidities, Substance Use, and Social Outcomes among Men and Women in a Canadian Sample.

Vingilis E, Erickson PG, Toplak ME, Kolla NJ, Mann RE, Seeley J, vanderMaas M, Daigle DS.

Biomed Res Int. 2015;2015:982072. doi: 10.1155/2015/982072. Epub 2015 May 3.

16.

Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults.

Koblan KS, Hopkins SC, Sarma K, Jin F, Goldman R, Kollins SH, Loebel A.

Neuropsychopharmacology. 2015 Nov;40(12):2745-52. doi: 10.1038/npp.2015.124. Epub 2015 May 7.

17.

Genome-wide analysis of attention deficit hyperactivity disorder in Norway.

Zayats T, Athanasiu L, Sonderby I, Djurovic S, Westlye LT, Tamnes CK, Fladby T, Aase H, Zeiner P, Reichborn-Kjennerud T, Knappskog PM, Knudsen GP, Andreassen OA, Johansson S, Haavik J.

PLoS One. 2015 Apr 13;10(4):e0122501. doi: 10.1371/journal.pone.0122501. eCollection 2015.

18.

Prevalence and correlates of attention-deficit hyperactivity disorder symptoms in Korean college students.

Kwak YS, Jung YE, Kim MD.

Neuropsychiatr Dis Treat. 2015 Mar 23;11:797-802. doi: 10.2147/NDT.S80785. eCollection 2015.

19.

Cortisol Response to Stress in Adults with Attention Deficit Hyperactivity Disorder.

Corominas-Roso M, Palomar G, Ferrer R, Real A, Nogueira M, Corrales M, Casas M, Ramos-Quiroga JA.

Int J Neuropsychopharmacol. 2015 Mar 17;18(9). pii: pyv027. doi: 10.1093/ijnp/pyv027.

20.

Cross-fostering differentially affects ADHD-related behaviors in spontaneously hypertensive rats.

Gauthier AC, DeAngeli NE, Bucci DJ.

Dev Psychobiol. 2015 Mar;57(2):226-36. doi: 10.1002/dev.21286. Epub 2015 Feb 2.

Supplemental Content

Support Center